Decreased liver density as a potential predictor of severe COVID-19: a retrospective cohort study
- Authors: Shumskaya Y.F.1,2, Akhmedzyanova D.A.2, Mnatsakanyan M.G.2
-
Affiliations:
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies
- Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 25, No 5 (2023): Gastroenterology
- Pages: 351-356
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/131678
- DOI: https://doi.org/10.26442/20751753.2023.5.202251
- ID: 131678
Cite item
Full Text
Abstract
Background. To stratify the risk in patients with COVID-19, it is important to understand the parameters that predispose to a severe course. Following risk factors were described: age over 60 years, overweight, male gender, chronic diseases: hypertension, diabetes mellitus. Low liver density on computed tomography (CT) is also considered as a potential risk factor.
Aim. To evaluation whether low liver density can be used as a predictor of severe COVID-19.
Materials and methods. Retrospective single-center cohort study. Patients with COVID-19 treated in a hospital setting, who underwent two CT scans of the thoracic organs in dynamics, were included. The patients were divided into groups according to the severity of the course (groups of moderate course, severe course and lethal outcome). Relation of the investigated factors was estimated using regression analysis.
Results. 99 patients were enrolled; 3 comparison groups were formed (moderate-severe course n=37, severe course n=52, lethal outcome n=8). All groups significantly differed in C-reactive protein levels. According to multivariate regression analysis, COVID-19 severity was influenced by the liver to spleen density ratio as measured by CT scan on admission [odds ratio 12.18 (95% confidence interval 1.67–89.07); p=0.008].
Conclusion. Reduced liver density on CT scan in a patient with COVID-19 may be a predictor of severe course of novel coronavirus infection.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Yuliya F. Shumskaya
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies; Sechenov First Moscow State Medical University (Sechenov University)
Email: shumskayayf@zdrav.mos.ru
ORCID iD: 0000-0002-8521-4045
SPIN-code: 3164-5518
Res. Assist.
Russian Federation, Moscow; MoscowDina A. Akhmedzyanova
Sechenov First Moscow State Medical University (Sechenov University)
Email: dina_akhm@mail.ru
ORCID iD: 0000-0001-7705-9754
SPIN-code: 6983-5991
Laboratory Technician
Russian Federation, MoscowMarina G. Mnatsakanyan
Sechenov First Moscow State Medical University (Sechenov University)
Author for correspondence.
Email: mnatsakanyan08@mail.ru
ORCID iD: 0000-0001-9337-7453
SPIN-code: 2015-1822
D. Sci. (Med.)
Russian Federation, MoscowReferences
- Liu YC, Kuo RL, Shih SR. COVID-19: The first documented coronavirus pandemic in history. Biomed J. 2020;43(4):328-33. doi: 10.1016/j.bj.2020.04.007
- Grasselli G, Greco M, Zanella A, et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy [published correction appears in JAMA Intern Med. 2021;181(7):1021]. JAMA Intern Med. 2020;180(10):1345-55. doi: 10.1001/jamainternmed.2020.3539
- Gupta S, Hayek SS, Wang W, et al. Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US [published correction appears in JAMA Intern Med. 2020;180(11):1555] [published correction appears in JAMA Intern Med. 2021;181(8):1144]. JAMA Intern Med. 2020;180(11):1436-47. doi: 10.1001/jamainternmed.2020.3596
- Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985. doi: 10.1136/bmj.m1985
- Karagiannidis C, Mostert C, Hentschker C, et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med. 2020;8(9):853-62. doi: 10.1016/S2213-2600(20)30316-7
- Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China [published correction appears in JAMA Intern Med. 2020;180(7):1031]. JAMA Intern Med. 2020;180(7):934-43. doi: 10.1001/jamainternmed.2020.0994
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020;395(10229):1038] [published correction appears in Lancet. 2020;395(10229):1038]. Lancet. 2020;395(10229):1054-62. doi: 10.1016/S0140-6736(20)30566-3
- Garibaldi BT, Fiksel J, Muschelli J, et al. Patient Trajectories Among Persons Hospitalized for COVID-19: A Cohort Study [published correction appears in Ann Intern Med. 2021;174(1):144]. Ann Intern Med. 2021;174(1):33-41. doi: 10.7326/M20-3905
- Dongiovanni P, Meroni M, Longo M, Fracanzani AL. MAFLD in COVID-19 patients: an insidious enemy. Expert Rev Gastroenterol Hepatol. 2020;14(10):867-72. doi: 10.1080/17474124.2020.1801417
- Yang RX, Zheng RD, Fan JG. Etiology and management of liver injury in patients with COVID-19. World J Gastroenterol. 2020;26(32):4753-62. doi: 10.3748/wjg.v26.i32.4753
- Мнацаканян М.Г., Погромов А.П., Лишута А.С., и др. Механизмы повреждения печени при COVID-19. Терапевтический архив. 2021;93(4):427-30 [Mnatsakanyan MG, Pogromov AP, Lishuta AS, et al. Liver and COVID-19: possible mechanisms of damage. Terapevticheskii Arkhiv (Ter. Arkh.). 2021;93(4):427-30 (in Russian)]. doi: 10.26442/00403660.2021.04.200733
- Bangash MN, Patel J, Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 2020;5(6):529-30. doi: 10.1016/S2468-1253(20)30084-4
- Shiralkar K, Chinapuvvula N, Ocazionez D. Cross-Sectional Abdominal Imaging Findings in Patients With COVID-19. Cureus. 2020;12(8):e9538. doi: 10.7759/cureus.9538
- Синицын В.Е., Тюрин И.Е., Митьков В.В. Временные методические рекомендации Российского общества рентгенологов и радиологов (РОРР) и Российской ассоциации специалистов ультразвуковой диагностики в медицине (РАСУДМ) «Методы лучевой диагностики пневмонии при новой коронавирусной инфекции при COVID-19» Российское общество рентгенологов и радиологов (РОРР), Российская ассоциация специалистов ультразвуковой диагностики в медицине (РАСУДМ). 2020 [Sinitsyn VE, Tiurin IE, Mit'kov VV. Vremennye metodicheskie rekomendatsii Rossiiskogo obshchestva rentgenologov i radiologov (RORR) i Rossiiskoi assotsiatsii spetsialistov ul'trazvukovoi diagnostiki v meditsine (RASUDM) “Metody luchevoi diagnostiki pnevmonii pri novoi koronavirusnoi infektsii pri COVID-19” Rossiiskoe obshchestvo rentgenologov i radiologov (RORR), Rossiiskaia assotsiatsiia spetsialistov ul'trazvukovoi diagnostiki v meditsine (RASUDM). 2020 (in Russian)].
- Морозов С.П., Проценко Д.Н., Сметанина С.В., и др. Лучевая диагностика коронавирусной болезни (COVID-19): организация, методология, интерпретация результатов: методические рекомендации. Серия «Лучшие практики лучевой и инструментальной диагностики». Вып. 93. М., 2021 [Morozov SP, Protsenko DN, Smetanina SV, et al. Luchevaia diagnostika koronavirusnoi bolezni (COVID-19): organizatsiia, metodologiia, interpretatsiia rezul'tatov: metodicheskie rekomendatsii. Seriia “Luchshie praktiki luchevoi i instrumental'noi diagnostiki”. Vyp. 93. Moscow, 2021 (in Russian)].
- Morozov SP, Reshetnikov RV, Gombolevskiy VA, et al. Diagnostic accuracy of computed tomography for identifying hospitalizations for patients with COVID-19. Digital Diagnostics. 2021;2(1):5-16. doi: 10.17816/DD46818
- Morozov SP, Chernina VYu, Blokhin AI, Gombolevskiy VA. Chest computed tomography for outcome prediction in laboratory-confirmed COVID-19: A retrospective analysis of 38,051 cases. Digital Diagnostics. 2020;1(1):27-36. doi: 10.17816/DD46791
- Pickhardt PJ, Graffy PM, Reeder SB, et al. Quantification of liver fat content with unenhanced mdct: phantom and clinical correlation with mri proton density fat fraction. Am J Roentgenol. 2018;211(3):W151-7. doi: 10.2214/AJR.17.19391
- Ji D, Qin E, Xu J, et al. Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study. J Hepatol. 2020;73(2):451-3. doi: 10.1016/j.jhep.2020.03.044
- Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052. doi: 10.1001/jama.2020.6775
- Wang X, Fang X, Cai Z, et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among covid-19 patients: a systemic review and meta-analysis. Research. 2020;2020/2402961. doi: 10.34133/2020/2402961
- Vila-Corcoles A, Satue-Gracia E, Vila-Rovira A, et al. COVID19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection: a population-based cohort study in Southern Catalonia, Spain, March–June 2020. BMC Public Health. 2021;21(1):1795. doi: 10.1186/s12889-021-11879-2
- Lei P, Zhang L, Han P, et al. Liver injury in patients with COVID-19: clinical profiles, CT findings, the correlation of the severity with liver injury. Hepatol Int. 2020;14(5):733-42. doi: 10.1007/s12072-020-10087-1
- Uchida Y, Uemura H, Yamaba S, et al. Significance of liver dysfunction associated with decreased hepatic CT attenuation values in Japanese patients with severe COVID-19. J Gastroenterol. 2020;55(11):1098-106. doi: 10.1007/s00535-020-01717-4
- Parlak S, Çıvgın E, Beşler M, Kayıpmaz A. The effect of hepatic steatosis on COVID-19 severity: Chest computed tomography findings. Saudi J Gastroenterol. 2021;27(2):105. doi: 10.4103/sjg.sjg_540_20
- Guler E, Unal NG, Cinkooglu A, et al. Correlation of liver-to-spleen ratio, lung CT scores, clinical, and laboratory findings of COVID-19 patients with two consecutive CT scans. Abdom Radiol. 2021;46(4):1543-551. doi: 10.1007/s00261-020-02805-y
- Zanon M, Neri M, Pizzolitto S, et al. Liver pathology in COVID-19 related death and leading role of autopsy in the pandemic. World J Gastroenterol. 2023;29(1):200-20. doi: 10.3748/wjg.v29.i1.200
- Graffy PM, Sandfort V, Summers RM, Pickhardt PJ. Automated liver fat quantification at nonenhanced abdominal CT for population-based steatosis assessment. Radiology. 2019;293(2):334-42. doi: 10.1148/radiol.2019190512
- Demkina AE, Morozov SP, Vladzymyrskyy AV, et al. Risk Factors for Outcomes of COVID-19 Patients: An Observational Study of 795 572 Patients in Russia. medRxiv. 2020. doi: 10.1101/2020.11.02.20224253
- Shumskaya YF, Gonchar AP, Mnatsakanyan MG, et al. Influence of Liver Attenuation on the Severity of Course COVID-19: A Retrospective Cohort Study. medRxiv. 2023. doi: 10.1101/2023.02.27.23286488